PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Miskulin, Dana C.
TI  - Ergocalciferol Supplementation in Patients Undergoing Hemodialysis is Safe but without Benefit
DP  - 2015 Feb 01
TA  - MD Conference Express
PG  - 11--12
VI  - 14
IP  - 49
4099  - http://mdc.sagepub.com/content/14/49/11.short
4100  - http://mdc.sagepub.com/content/14/49/11.full
AB  - Vitamin D deficiency has been linked to cardiovascular events and mortality, infection, and autoimmune disorders. Deficiency of 25-hydroxyvitamin D [25(OH)D] <30 ng/mL occurs in about 80% of patients undergoing dialysis. The double-blind, placebo-controlled Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients [NCT01395823] trial investigated the safety and effects of dosing on dialysis patients, as discussed in this article.